| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $6.7M | +21.1% |
| SG&A Expense | $8.5M | -28.8% |
| Operating Income | -$15.3M | +9.7% |
| Income Tax | $0 | — |
| Net Income | -$13.0M | +29.3% |
| EPS (Basic) | -$0.50 | +61.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.9M | +54.9% |
| Short-term Investments | $0 | -100.0% |
| Current Assets | $9.4M | -18.5% |
| Total Assets | $18.2M | -10.6% |
| Current Liabilities | $2.6M | -41.3% |
| Total Liabilities | $10.2M | +62.7% |
| Stockholders' Equity | $8.0M | -43.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.7M | +27.5% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $3.8M | +816.1% |
| Financing Cash Flow | $12.0M | +247.5% |
| Free Cash Flow | -$12.7M | +27.9% |